Following the Company’s Fix, Fund, Propel approach, Navidea formally submitted a request for an oral hearing with New York Stock Exchange American Hearing Panel to appeal potential delisting of. -Today at 09:30 am- MarketScreener
Navidea Biopharma (NAVB) Requests Oral Hearing With NYSE Hearing Panel streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.